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Essential fatty acid (EFA)' deficiency is remarkably protective against immune-
mediated renal disease . Mortality from murine lupus, due largely to immune-mediated
glomerulonephritis, is substantially attenuated by the deficiency state (1) . We have
observed a similar beneficial effect in immune-mediated glomerulonephritis using
the model of nephrotoxic nephritis in rats (2). The influx of macrophages into the
glomerulus in this model is completely prevented by EFAdeficiency, and subsequent
proteinuria (an indicator of the renal injury) is decreased -90% . Studies on inter-
stitial nephritis induced by the administration of puromycin aminonucleoside have
also established that EFAdeficiency prevents the influx of macrophages into therenal
interstitium and concomitantly prevents expected reductions in glomerular filtra-
tion and renal blood flow (3) . A protective effect of EFA deficiency is also seen in
the interstitial inflammation that accompanies experimental hydronephrosis (4) .
Recently, we have shown that such protective effects are not limited to renal dis-
eases . Using the low dose streptozotocin-treated mouse model ofautoimmune dia-
betes, we observed that EFAdeficiency completely prevents both pancreatic insulitis
and hyperglycemia (5). To extend our understanding of these protective effects, the
present experiments were undertaken to study the influence of EFA deficiency on
diabetes in the BB rat .
Diabetes-prone (DP)-BB rats develop a heritable, ketosis-prone diabetes syndrome
similar to human insulin-dependent diabetes mellitus, and many lines of evidence
suggest an autoimmune pathogenesis of diabetes in both disorders (6-8). Islet au-
toantibodies are present (9), the pancreatic islets of diabetic rats are infiltrated by
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lymphocytes (an inflammatory lesion termed insulitis), and adoptive transfer dia-
betes has been demonstrated (10, 11). The DP-BB rat also has severe T cell lym-
phopenia (12) with reduced numbers of CD4' and CD8' T cells and complete ab-
sence of RT6' T cells (13, 14). Several immunosuppressive interventions, including
cyclosporine (15), thymectomy (16), antilymphocyte serum (17), silica (18, 19), and
total lymphoid irradiation (20), prevent diabetes in the BB rat. In addition, at least
one immunomodulatory intervention, lymphocyte transfusion, prevents both dia-
betes and insulitis (21, 22).
The diabetes-resistant (DR)-BB rat was derived from DP forebears but bred for
resistance to the disease (7, 23). It has a cumulative incidence of diabetes of <1%.
In contrast to DPs, DR-BB rats have normal numbers and a normal distribution
of all lymphocyte phenotypes, including RT6' cells. The rare DR animals that do
become diabetic are not lymphopenic (24). However, in vivo immune elimination
of RT6' T lymphocytes in DR rats by administration of anti-RT6.1 lymphotoxic
antibody precipitates diabetes in -50% of 30-d-old animals within 3-4 wk (25).
Cells expressing the RT6 antigen in the rat (x+50% of CD4' and -70% CD8+ T
lymphocytes) are believed to exert a regulatory influence on the immune system,
and the RT6-depleted DR-BB rat is used as a model of inducible autoimmune dia-
betes (26).
In the present study, we show that EFA deficiency protects against diabetes in
both DP and RT6-depleted DR animals. The degree of protection, however, was
found to be somewhat variable. This variability provided us with an opportunity
to examine the relationship between this physiological effect of EFA deficiency and
its biochemical effects.
EFA deficiency is characterized by depletion of essential (n-6) polyunsaturated
fatty acids and accumulation of (n-9) polyunsaturated fatty acids. Linoleate and
its desaturation/elongation product, arachidonate, are both depleted (27). In lieu
of these fatty acids, oleate accumulates and is desaturated and elongated into the
fatty acid 20:3(n-9), which is normally not synthesized andwhose accumulation serves
to define thedeficiency state(27). Consequently, EFA deficiency is notonly adeficiency
state, but is also a condition characterized by accumulation of an abnormal fatty
acid, 20:3(n-9), which, like arachidonate, can be metabolized to a variety of poten-
tially active biological mediators (28-30). Interpreting the effects of EFA deficiency
has heretofore been problematic in that there has been no prima facie evidence as
to whether any biological effect is due to the depletion of (n-6) fatty acids (or their
metabolites) or the accumulation of (n-9) fatty acids (or their metabolites). In the
present study, however, the response to EFA deficiency exhibited some variability,
andwe were thus able to correlatethephysiologicaleffect ofthedeficiency statedirectly
with its biochemical effects. The results suggest that depletion of (n-6) fatty acids
may be the key biochemical variable affected by EFA deficiency.
Materials and Methods
Animals.
￿
BB rats were obtained from the University of Massachusetts, Worcester. Animals
from this colony are designated BB/Wor. The cumulative incidence of disease in the DP line
of BB/Wor rats is 40-70% ; >85% of all cases appear between 60 and 120 d of age; <0.5%
appear before 60 d of age (7). Both sexes are equally susceptible. The cumulative incidence
of diabetes among DRBB/Wor rats is <1% among >20,000 animals studied.LEFKOWITH ET AL.
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Except where noted, rats in the present studies were 22-30 d old when entered into experi-
ments, were housed under standard laboratory conditions, given ad libitum access to food
and water, and were weighed and tested for glycosuria (TesTape; Eli Lilly, Inc., Indianapolis,
IN) twice weekly. Diabetes was diagnosed on the basis of glycosuria and a plasma glucose
concentration >250 mg/dl, as determined by a glucose analyzer (Beckman Instruments, Inc.,
Fullerton, CA).
Reagents and Materials.
￿
Polyunsaturated fatty acid methyl esters for gas chromatography
standards were purchased from Sigma Chemical Co. (St. Louis, MO), except for 20:3(n-9)
methyl ester, which was purchased from Biomol (Plymouth Meeting, PA). Silica gel plates
for the isolation of fatty acid methyl esters (20 x 20 cm, 0.25 mm) were purchased from
Analabs (North Haven, CT). Chemicals were purchased from Burdick &Jackson Laborato-
ries Inc. (Muskegon, MI) and were HPLC grade.
Dietary Studies.
￿
Two diets were used in this study. The control diet consisted of standard
Purina 5001 Rodent Laboratory Chow. The EFA-deficient diet was purchased from Purina
Test Diets (Richmond, IN) and contained casein (vitamin free, 21%), sucrose (68.85%),
dl-methionine (0.15%), non-nutritive fiber (3%), vitamin mixture (2%), choline chloride
(0.2%), and mineral mixture (5%). The EFA-deficient diet was periodically monitored for
fatty acid content and consistently contained <10 Wg of linoleate per gram of food and no
detectable arachidonate. Animals (22-25 d ofage) were starved for 24 h to augment the deple-
tion ofessential fatty acids, and then were begun on the EFA-deficient diet. All experiments
were performed using both male and female rats.
Experiment 1 was carried out with DP-BB rats in two separate trials. In the first trial,
DP animals were maintained on either the control or EFA-deficient diet through 120 d of
age. or until they became diabetic. Animals were killed when they became diabetic or at 120 d
of age, and samples of liver and pancreas were obtained. Livers were frozen at -20'C for
later lipid analysis (see below). Pancreata were fixed in Bouin's solution, embedded in paraffin,
stained with hematoxylin and eosin, and studied for the presence of insulitis by light micros-
copy. The second trial in Experiment 1 was identical except that the rats were studied through
200 d of age.
Experiment 2 was carried out using the RT6-depleted DR-BB rat model. Newly weaned
littermates, 22 d of age, were fasted for 24 h and then randomized to receive either the control
or EFA-deficient diet. 7 d later, they began treatment with DS4.23 anti-RT6.1 antibody (25).
The antibody was injected intraperitoneally, 2 ml/rat, five times/wk, in the form of superna-
tants obtained from primary cultures maintained in our laboratory. Injections were continued
for 4 wk. Animals were killed when they developed diabetes, or between 62 and 71 d of age.
Lymphocyte subset analysis was performed using standard flow microfluorimetry methods,
as previously described (7), on a sample of rats in both groups to confirm depletion of RT6'
T cells. The experiment was performed as three separate trials as litters of rats became avail-
able. Pancreatic histology was performed on the nondiabetic rats at the end ofthe third trial only.
To control for the previously recognized (27) growth retardation that occurs in EFA-depleted
animals, a third experiment was performed in which male and female littermate DP rats
were randomized to receive either Purina rat chow ad libitum or a diet limited to 6 g of the
same chow daily. The amount ofchow given to the food-restricted group had previously been
determined to be the average amount consumed by 40-d-old DP-BB/Wor rats. Both ex-
perimental and control animals were weighed and tested for diabetes through 120 d of age.
They were then killed and not studied further.
The fourth experiment investigated the effect of linoleate repletion in BB rats previously
made EFA deficient. As in the first experiment, DP-BB rats were randomized to the EFA-
deficient or the control diet. Beginning at 70 d of age, half of the EFA-deficient rats were
begun on linoleate given as the free acid (Sigma Chemical Co.), 1 ml/rat three times weekly
by orogastric gavage, until the animals were 163 d of age. In a second trial, an identical pro-
tocol was used except that linoleate repletion was begun at 120 d of age and continued through
156 d. Control animals were not gavaged.
Lipid Analysis.
￿
Lipids from samples of liver were extracted by the method of Bligh and
Dyer (31). Fatty acids were then transmethylated by the sequential addition of 0.5 N NaOH
in methanol and 6 N HCI. Fatty acid methyl esters were extracted with hexane/diethyl ether,732
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1 :1, and separated by thin layer chromatography (hexane/diethyl ether/acetic acid, 75:5:1).
Fatty acid methyl esters were identified by comigration with authentic standard, the appro-
priate band was scraped, and the methyl esters were eluted from the plate with hexane/diethyl
ether, 1 :1 .
Fatty acid methyl esters were characterized and quantified by gas chromatography using
a gas chromatograph (5890) interfaced with an integrator (3393A; Hewlett-Packard Co., Palo
Alto, CA). The column used was an SP-2380 capillary column (0.32-mm diameter, 30-m
length) from Supelco, Inc. (Houston, TX), and was run at 170°C isothermally. The injector
was maintained at 250°C and the flame ionization detector at 300°C. Peaks were identified
by comigration with authentic standards and quantified by the integrator. Results are ex-
pressed as mole percent.
Statistical Analysis.
￿
Nonparametric data are presented as 2 x N tables and were analyzed
using either the Fisher exact statistic or the Xz statistic. Parametric data are for the most part
presented as mean ± SEM, and were analyzed using the unpaired t test or one-way analysis
of variance. Data on the relationship of the change in fatty acids and the onset of diabetes
were analyzed by linear regression to obtain correlation coefficients and p values. A total
of 12 animals that died acutely during gavage with linoleate have been excluded from all anal-
yses; details are given in the text. A very small number of animals found dead in their cages
have also been excluded from analysis.
Results
Effects ofEFA Deficiency on theDiabetes andInsulitis in theDFBB Rat.
￿
We examined
the effect of the deficiency state on the frequency of spontaneous diabetes in the
DP rat in two independent trials carried out through 120 and 200 d of age, respec-
tively. As shown in Table I, EFA deficiency substantially decreased the incidence
ofdisease and delayed its onset in both trials. In the first trial, EFA deficiency markedly
reduced the incidence of diabetes but did not completely prevent its occurrence.
The cumulative incidence of diabetes in EFA-deficient animals was 29%, as com-
pared with 80% in controls (p <0.005). When the occurrence ofinsulitis, the patho-
logical substrate of autoimmune diabetes, was taken into account, the relative pro-
tective effect ofthe EFA-deficient state was still apparent; 100 % ofcontrols were affected
with either diabetes or insulitis, as compared with only halfofrats on the EFA-deficient
diet (p <0.0005). The mean age at onset of diabetes was somewhat greater in EFA-
deficient animals (104 t 5 d) compared with controls (98 f 4 d), but this difference
did not reach statistical significance. The body weight of nondiabetic rats at 90 d
of age (the mean age at which diabetes generally occurs in DP rats) is also indicated
in Table I, and shows the mild growth-retarding effect of the EFA-deficient state,
which averaged 56 g for males and 18 g for females.
The occurrence ofinsulitis in several nondiabetic EFA-deficient rats and the trend
toward later onset among diabetic EFA-deficient animals suggested the possibility
that the diet had delayed rather than prevented diabetes. This possibility was ad-
dressed in the second trial of Experiment 1, which extended the treatment period
to 200 d of age. It confirmed the observations reached in the first trial. As shown
in Table I, EFA deficiency again reduced (to 35%), but did not completely block,
the occurrence of diabetes (which reached 65% in controls, p <0.05). In this trial,
we did observe that EFA deficiency also delayed the mean age of onset of diabetes:
121 ± 6 d of age for the EFA-deficient group vs. 104 t 4 d of age for controls
(p <0.05). Unfortunately, technically inadequate and therefore uninterpretable
histology on six of the seven nondiabetic control pancreata precluded a comparative
analysis of the frequency ofinsulitis. We can report, however, that insulitis was found-o
LEFKOWITH ET AL.
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in only 5 ofthe 14 pancreata (36%) obtained from 200-d-old nondiabetic EFA-depleted
rats. Thus, this second trial confirmed that EFA deficiency prevented, and did not
simply delay, diabetes in the DP-BB rat.
Effect ofEFA Deficiency on theFrequency ofDiabetes in RT6-depleted DR-BB Rats.
￿
Typi-
cally, about half of DR-BB rats treated with a cytotoxic antibody directed against
RT6+ lymphocytes develop diabetes (25) . Using this model, EFA deficiency was even
more strikingly protective. As shown in Table II, 28% of RT6-depleted DR controls
(n = 29) developed diabetes, whereas no antibody-treated EFA-deficient animals
(n = 26) developed diabetes. Lymphocyte subset analysis confirmed that anti-RT6
antibody depleted RT6+ T cells in the EFA-deficient animals to the same degree
as in the controls (data not shown).
EFA deficiency was also associated with the absence of insulitis in nondiabetic
animals in the third trial ofExperiment 2 . Among 12 EFA-deficient rats in this trial,
none developed either diabetes or insulitis. Among 13 controls, three became dia-
betic and three of the nondiabetic pancreata showed insulitis. Considering insulitis
and diabetes together, the difference between the two groups was statistically significant
at the p <0.02 level.
Effect ofLinoleate Repletion ofEFA-deficient BB Rats.
￿
To determine if the protective
effect of EFA deficiencywas specifically due to deprivation of (n-6) fatty acids, EFA-
deficient DP-BB rats were repleted with linoleate at two time points. Repletion was
begun either at 70 d of age (the age by which diabetes has begun to appear in control
animals) or at 120 d of age (after the peak incidence of spontaneous diabetes in DP
rats). These two experiments also addressed whether the protective effect of the
deficiency state was absolutely dependent on the altered fatty acid composition or
whether a more permanent alteration in susceptibility could be effected.
Linoleate repletion of EFA-deficient DP animals at 70 d of age appeared to restore
their susceptibility to diabetes (Table III). The incidence of diabetes through 163 d
of age in repleted EFA-deficient animals was intermediate between control and EFA-
deficient animals, and was not significantly different from either, although there was
a trend towards a difference from EFA-deficient animals. The effect oflinoleate reple-
tion was more apparent when the frequency of insulitis was taken into account. Ei-
TABLE II
Effect of EFA Depletion on the Frequency of Diabetes and Insulitis in the RT6-depleted DR-BB Rat
Overall results
￿
Results of trial 3
Mean age
￿
No. of diabetics
No. with
￿
at onset of
￿
No. with
￿
studied
￿
No. of nondiabetics
￿
No. with diabetes
Diet
￿
diabetes
￿
diabetes
￿
diabetes
￿
histologically
￿
with insulitis
￿
or insulitis
d
EFAD
￿
0/26 (0%)'
￿
-
￿
0/12 (0%)
￿
12
￿
0/12 (0%)1
￿
0/12 (0%)9
Control 8/29 (287o)
￿
60 t 2
￿
3/13 (23%)
￿
10
￿
3/10 (30%)
￿
6/13 (467.)
The study was carried out in three trials as litters became available. Histologic study was included as part
of the third trial only. Depletion of RT6' T cell populations to undetectable (<5%) levels was confirmed
in a random sampling of rats from both the experimental and control groups. The animals tested histologi-
cally were selected from among littermates randomized to the two conditions as part of the third trial.
* p < 0.01 vs. controls.
I p < 0.09 vs. controls.
4 p < 0.005 vs. controls.LEFKOWITH ET AL.
TABLE III
Effect of EFA Depletion and Subsequent Linoleate Repletion on the Frequency of
Diabetes and Insulitis in the DP-BB Rat
A total of 33 experimental rats were begun on the EFA-deficient diet at 22 d of age after
a 24-h fast . At 70 d of age, a total of 17 ofthese animals were selected at random and begun
on a regimen of linoleate repletion (1 ml/rat, three times weekly) by gavage . Six of these
animals died acutely during the administration of linoleate and have been excluded from
the analysis. All rats were tested for diabetes through 163 d of age.
' Overall X2 = 13.40, df = 2, p < 0 .01 ; p < 0.001 vs. control diet group; no other paired
comparisons are significant.
1 Overall X2 = 13.14, df = 2, p < 0.01; p < 0.01 vs. both the linoleate repleted group and
the control diet group; no other paired comparisons are significant. There were no statisti-
cally significant differences in the age at onset of diabetes (F = 2.54, p = NS).
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ther diabetes or insulitis was observed in nearly all controls (as seen above), as well
as in most repleted EFA-deficient animals. In contrast, 63 % ofEFA-deficientanimals
(10/16) were free of both diabetes and its pathological substrate, insulitis.
The study of linoleate repletion begun at 120 d of age was carried out to comple-
tion in 11 controls, but only six EFA-deficient animals; six additional EFA-deficient
rats died acutelywhile being gavaged between 130 and 156 d ofage. Through 120 d
ofage, 5 of the 11 control DP rats, but none of the 12 EFA-deficient animals, became
diabetic. Between 120 and 156 d of age, no additional control animals became dia-
betic, nor did diabetes appear in any of the six surviving linoleate-repleted EFA-
deficient rats. Histologic studyof the six pancreata from these EFA-deficient, linoleate-
repleted rats revealed insulitis in only one. Parenthetically, we note also that none
of the six rats that died acutely during linoleate gavage (between 10 and 36 d after
its institution) were diabetic ante mortem.
Relationship ofBody Weight andDiabetes Frequency.
￿
Because EFAdeficiency is known
to cause modest growth retardation, the question arose as to whether the protective
effect of the deficiency state might be due simply to a decrease in body weight . As
wasexpected on the basis of previous experience, EFA-deficient rats grew at a slower
rate than did controls (Table I) . However, it was observed in the third experiment
that simple starvation resulting in an even greater degree of growth retardation was
not associated with any reduction in the frequency of diabetes (Table IV).
Additional information bearing on this issue wasobtained from the linoleatereple-
tion experiments. As was the case in Experiment 1 (Table I), EFA deficiency led
to a 10-30% decrease in body weight in both male and female animals. Repletion
of EFA-deficient animals with linoleate at 70 d of age, however, did not lead to a
significant gain in weight in repleted animals (data not shown). Nonetheless, as de-
scribedabove, repleted animalsexhibited adegree of susceptibility to diabetes similar
to that of control animals, suggesting that simple growth retardation wasnotsufficient
to decrease the incidence of diabetes.
No. with
Mean age
at onset of
No. of
nondiabetics
No. with
diabetes
Diet diabetes diabetes with insulitis or insulitis
d
EFAD 3/16 (19%)' 136 t 5 3/13 (23%) 6/16 (38%)1
EFAD and linoleate 6/11 (55%) 106 f 7 4/5 (80%) 10/11 (91%)
Control 14/17 (82%) 105 t 7 1/3 (33%) 15/17 (88%)736
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TABLE IV
Effect of Caloric Restriction on the Frequency of Diabetes in Male and Female DP-BB Rats
Body weights are given for rats at three different ages: 60 d, when the first cases of diabetes
appear; 90 d, when the incidence of diabetes is maximal; and 115 d, when most cases of dia-
betes have already appeared. Ages when weights were measured are approximate ( t 3 d) due
to variation in date of birth. All calorie-restricted rats were begun on this regimen at 30 d of
age. The amount of food given these rats was based on the average amount consumed by a
group of 40-d-old DP rats. The number of animals at each successive data point declines due
to the elimination of diabetic rats from further study. All rats were studied through 120 d of
age. There are no statistically significant differences in the frequency of diabetes or its age at
onset among any of the four groups.
Relationship betweenthePhysiologicalandBiochemical Effects ofEFADeficiency.
￿
As shown
in Table V EFA deficiencyled to marked decreases in hepatic (n-6) fatty acids (i.e.,
linoleate and arachidonate), as well as to the accumulation of(n-9) fatty acids, oleate
and 20:3(n-9), in the DP-BB rats that were part of Experiment 1. The aggregate
20:3(n-9) to arachidonate ratio ofEFA-deficient animals was 3.0, well above the 0.4
ratio used as thebiochemical definition ofthedeficiency state (27). Because the pro-
tective effect ofthe deficiency state was not universal in our initial experiment, we
sought to determine ifthedegree ofdeficiency mightcorrelatewithdisease suscepti-
bility. Thehepatic fatty acid analysis ofdiabetic andnondiabetic EFA-deficient animals,
TABLE V
Hepatic Fatty Acid Analysis of DP-BB Rats
Liver lipids from DP-BB rats were extracted and the constituent fatty acids transmethylated for analysis
by gas chromatography as detailed in Materials and Methods. Quantitation of the major (n-9) and (n-6)
polyunsaturated fatty acids are shown together with the 20:3(n-9) to arachidonate ratio. 18:1(n-9), 18:2(n-6),
and 20:4(n-6) represent oleic, linoleic, and arachidonic acids, respectively. Results are expressed as mole
percent.
p < 0.01, EFAD or EFAD plus linoleate vs. controls.
1 p < 0.05, EFAD plus linoleate vs. controls.
Sex Diet -60 d
Body weight
-90 d
g
-115 d
No. with
diabetes Percent
Mean age
at onset
d
Male ad libitum 231 t 11 303 t 8 347 ± 12 8/12 75 97 ± 5
(n = 12) (n = 10) (n = 4)
Male 6 gm/d 98 t 2 107 f 5 119 ± 5 5/9 56 84 f 5
(n = 9) (n = 6) (n = 4)
Female ad libitum 168 ± 5 216 t 12 233 ± 16 3/9 33 89 ± 5
(n = 9) (n = 8) (n = 6)
Female 6 gm/d 88 t 2 99 ± 5 112 t 5 6/11 55 82 ± 4
(n = 11) (n = 7) (n = 5)
Experimental group 18:1(n-9) 18:2(n-6)
Fatty acid
20:3(n-9) 20:4(n-6)
20:3(n-9)
20:4(n-6)
Controls (n = 4) 12 .3 t 0.3 14.2 t 1 .0 - 13 .2 t 1 .9 -
EFAD (n = 17) 35 .5 t 1 .8" 2.2 t 0.7' 8.2 t 0.8' 4.2 t 0.8' 3.0 f 0.4'
EFAD + linoleate (n = 7) 29.3 t 1 .9' 4.4 t 1 .2' 0.4 t 0.1' 5.0 t 1 .2' 0.1 t 0.01LEFKOWITH ET AL.
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as an indexoftheir response tothe diet, was thereforecompared. As shown in Table
VI, diabetic EFA-deficient animals in general exhibited less marked changesin fatty
acids. This association appeared particularly strong for the (n-6) fatty acids. EFA-
deficient animals that developed diabetes tended to have more nearly normal levels
oflinoleate and arachidonate than did the nondiabetic EFA-deficient animals. In-
terestingly, although EFA-deficient animals that developeddiabetes had lowerlevels
ofoleate, theirlevels of20:3(n-9)were no different from thoseofnondiabetic animals.
To strengthen this association, we next sought to determine if, in the group of
EFA-deficient animals that did become diabetic, there was a correlation between
age at onset ofdiabetes with changes in the major polyunsaturated fatty acids. As
shown in Fig. 1, the age at onset ofdiabetes in this subgroup showed a significant
negative correlation with the level of both linoleate and arachidonate. The more
depleted of(n-6) fatty acids an animal was, thelonger it was resistant to the develop-
ment ofdisease. With respect to the (n-9) fatty acids, therewasa significant positive
correlation with the level of oleate, but there was no apparent correlation with the
level of 20:3(n-9). Thus, these data corroborate those presented above, in that the
degree ofchange in fatty acids, particularly(n-6) fattyacids, appeared to be related
to disease susceptibility.
We subsequently examined theeffect oflinoleate repletion on fatty acid composi-
tion andthe propensity to develop diabetes. As shown in Table V, linoleate repletion
at 70 d ofage potently suppressed levels of20:3(n-9) and decreased levels ofoleate.
Linoleate and arachidonate levels were only modestly affected. Nonetheless, the
20:3(n-9) to arachidonate ratio of these animals was in the normal range. When
linoleate-repleted EFA-deficient animalswere dividedinto diabetic and nondiabetic
subgroups, the only apparent difference in fatty acid composition was in the level
ofarachidonate (Table VI). Arachidonate levels in diabetic animals were morenearly
normal than in nondiabetic animals. Thus, disease susceptibility in these experi-
ments correlated most closely with the level of arachidonate.
TABLE VI
Hepatic Fatty Acid Analysis of EFA-deficient and Linoleate-supplemented EFA-deficient
DP-BB Rats: Diabetics vs. Nondiabetics
Liver lipids from EFAD- and EFAD-linoleate-supplemented DP rats were extracted and the
constituent fatty acids transmethylated and analyzed by gas chromatography as detailed in
Materials and Methods. Quantitation ofthe major (n-9) and (n-6) polyunsaturated fatty acids
are shown along with the 20:3(n-9) to arachidonate ratio. 18:1 (n-9), 18:2(n-6), and 20:4(n-6)
represent oleic, linoleic, and arachidonic acids, respectively. Results are expressed as mole
percent . Animals were divided into nondiabetic and diabetic groups for comparison.
* p < 0.01, nondiabetic vs. diabetic.
1 p < 0.05, nondiabetic vs. diabetic.
Experimental group 18 :1 (n-9)
Fatty acid
18:2(n-6) 20:3(n-9) 20:4(n-6)
20:3(n-9)
20:4(n-6)
EFAD
Nondiabetic (n = 9) 40.5 f 0.9 0.9 t 0.2 7.5 ± 0.8 2 .0 t 0.3 4.2 t 0.4
Diabetic (n = 8) 30.1 ± 2.7* 3.6 ± 1 .31 9.1 f 1 .5 6.7 ± 1 .2* 1 .7 t 0.4*
EFAD + linoleate
Nondiabetic (n = 3) 31 .5 f 1 .8 3.1 t 1 .7 0.4 ± 0.1 2 .9 t 0.6 0.2 t 0.0
Diabetic (n = 4) 26.3 t 3.5 6.0 t 1 .3 0.4 ± 0.1 7 .8 f 1 .51 0.1 f 0.0738
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abetic DP-BB rats by gas chromatog-
raphy as detailed Materials and Meth-
0 ods. The levels of the major (n-9) and
(n-6) polyunsaturated fatty acids and
the 20:3(n-9) to arachidonate ratio
were correlated with the time of onset
of diabetes. 18:1(n-9), 18:2(n-6), and
20:4(n-6) represent oleic, linoleic, and
arachidonic acids, respectively. Corre-
lation coefficients andp values are: oleic
acid, r = 0.84, p <0.05; 20:3(n-9), r =
0.07, p = NS; linoleic acid, r = 0.67,
p <0.05; arachidonic acid, r = 0.76, p
<0.05; 20:3(n-9) to arachidonate ratio,
r = 0.66, p <0.05.
Discussion
Previous studies have provided strong evidence that diabetes in the BB rat is an
autoimmune process (6, 7). Asnoted above, lymphocytes from acutely diabetic DP-
BB rats adoptively transfer the disease, and various immunosuppressive regimens
ameliorate it. In the DRBB rat, diabetes is induced by in vivo immune elimination
of its RT6+ T cells. The present data indicate clearly that an environmental ma-
nipulation (EFA depletion) can preventdiabetes in both DP and RT6-depleted DR
BB rats.
The fact that only about halfofinbred DP or RT6-depleted DR rats become dia-
betic has suggested to many investigatorsthat there may bea role for environmental
perturbants inthisdisorder. In previous studies ofthe BB rat, however, the potential
importance ofenvironmental factors, such as diet, hormonal state, stress, and infec-
tion, in this disease model has been unclear. The appearance ofdiabetes in BB rats
reared in a gnotobiotic environment has excluded horizontal but not vertical trans-
mission of an infectious agent (32), yet the incidence of diabetes is reportedly re-
duced by infection with lymphocytec choriomeningitis virus (33). Hormonal ma-
nipulations such as hypophysectomy and castration, pancreatic parasympathetic
denervation by vagotomy, agents that protect against(3 cell injury (3-0-methyl glu-
cose and niacinamide), and stress have all been investigated in the BB rat and found
not to affect disease incidence (34). We have previously reported that diets high inLEFKOWITH ET AL.
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carbohydrate, fat, or protein were also ineffective in preventing diabetes (34), but
otherinvestigators report thatsemisyntheticdietsbased on casein or utilizingL-amino
acids reduce the frequency ofdiabetes, whereas those based on wheat gluten increase
it (35, 36). Dietscontaining omega-3 fatty acids(fish oil) alsoinfluence the frequency
ofdiabetes (37). The physiological and biochemical basis ofthe protective effect ex-
erted by dietary manipulations in the BB rat have to date remained obscure.
In previous studies, we observed that the dietary manipulation ofEFA deficiency
is remarkably protective in certain models ofautoimmune disease. Recently, we es-
tablished that EFA deficiency completely prevents the insulitis and diabetes in the
low dosestreptozotocin-induced model ofdiabetes (5). Thisstudyprovided theimpetus
to investigate the effects of EFA deficiency on diabetes in the BB rat. The present
study extends our prior observations and establishes the protective effect of the
deficiency statein both the spontaneously diabeticDP-BB rat andthe RT6-depleted
DR-BB rat. In these models, EFA deficiency markedly decreased the incidence of
diabetes and insulitis. In addition, it moderately delayed the onset of the disease
in EFA-deficient DP animals that nonetheless did become diabetic. The protective
effect of EFA deficiency was reversed by selective supplementation of DP-BB rats
with linoleate at 70 dofage, but not when linoleate wasbegun at 120d ofage. These
results confirm and extend previous suggestions (38) that DP rats are susceptible
to immunomodulation ofdiabetes only during a critical period that extends to ti2
mo of age. If protected during this vulnerable period, they will not subsequently
develop diabetes.
The beneficial effect of EFA deficiency did not appear to be a simple function
of a decrease in body weight. Linoleate-supplemented EFA-deficient BB rats were
nearly identical in weight to EFA-deficient animals, but exhibited a degree of sus-
ceptibility to diabetes comparable with that of control animals. These results are
corroborated by our independent result showing that caloric restriction and body
weight, per se, are not determinants of the expression of diabetes in the BB rat.
Although EFA deficiency was virtually completely protective in thelow-dose strep-
tozotocin model in mice in our previous studies (5), the deficiency state was not
as absolutely protective in the present studies on the DP-BB rat. This could be in
part due to the fact thatdiabetes develops between 60 and 120 d ofage in this model
ofdiabetes. Since it takes weeks to make animals fully EFA deficient (27), insulitis
in these animals may be developing at a time when the animals are incompletely
EFA deficient. In our prior studies usingthe low-dose streptozotocin model in mice,
it was possibleto makeanimals fully EFA deficient before the induction ofdisease (5).
Because the response to this dietary manipulation was not absolute in the DP-BB
rat, we were afforded the unique opportunity to examine the relationship between
the fatty acidchanges induced byEFAdeprivation with itsphysiological effects. These
experiments suggest that thedepletioncomponent ofthe EFA deficiency state, rather
than the accumulation of (n-9) fatty acids, particularly the abnormal 20:3(n-9), is
ofparamount importance in diabetes prevention. In particular, the depletion ofthe
(n-6) fatty acid, arachidonate, appeared to correlate closely with disease suscepti-
bility. This observation is not an obvious consequence ofEFA deficiency. Although
it is well appreciated that EFA deficiency may lead to a decrease in arachidonate
with alterations in the production ofprostaglandins, thromboxanes, andleukotrienes
(39, 40), it is less well known that 20:3(n-9), like arachidonate, can be metabolized740
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to a variety of eicosanoids that are potentially bioactive (28-30). Consequently, it
has heretofore not been apparent biochemically how EFA deficiency exerts its effects.
The exact mechanisms underlying the protective effect of EFA deficiency, how-
ever, remain to be fully elucidated. It appears that the effects of EFA deficiency are
not mediated through gross alterations in humoral or cellular immunity, as these
immunologic functions are basically intact in EFA-deficient animals (41). Two alter-
native (and not mutually exclusive) explanations for the beneficial effects of the
deficiency state in autoimmune disease are under consideration. First, there could
be a lack of a critical lipid mediator (e.g., arachidonate or a metabolite derived there-
from) involved in the initiation of the immune injury. Alternatively, there could be
a decrease in the influx of macrophages into the focus of insulitis.
Regarding the first possibility, studies have shown a decrease in the generation
of lipid mediators such as leukotriene B4 (40) and platelet-activating factor (42) with
EFA deficiency. Both of these substances may act to attract leukocytes to a focus
of inflammation (43, 44). It is currently unknown, however, whether islets can syn-
thesize either of these mediators.
The potential importance of macrophages to diabetes in the BB rat has recently
been highlighted by studies showing that macrophages are an early constituent of
the insulitis in this model (19). In addition, it has been shown that the administra-
tion of silica, a crude macrophage toxin, prevents diabetes in the DP-BB rat (18,
19, 45). Furthermore, studies suggest that certain cytokines of macrophage origin
may inhibit /3 cell function and lead to /3 cell destruction (46). The hypothesis that
the beneficial effects of the deficiency state may be mediated through its effects on
macrophages is supported by recent studies on glomerulonephritis. In normal animals,
the glomerulus is populated with resident macrophages (47). These cells are absent
from the glomerulus in EFA deficiency and return with supplementation of (n-6),
but not (n-3), fatty acids (47). In the context ofacute glomerulonephritis, leukocytes
invade the glomerulus; polymorphonuclear neutrophils predominate early on fol-
lowed by macrophages (2). EFA deficiency selectively prevents the influx of macro-
phages in this model of tissue injury (2) .
In conclusion, EFA deficiency significantly reduces the frequency of diabetes in
both the DP and in the RT6-depleted DR-BB/Wor rat . These effects appear to be
the consequence of the depletion of arachidonate. We would conjecture that a lipid
mediator (possibly a metabolite ofarachidonate) and macrophages are key elements
in the development of insulitis in this model. EFA deficiency would appear to exert
its protective effect through alterations of arachidonate metabolism, as well as on
macrophage function and/or migration. Hopefully, further understanding of the mech-
anisms underlying the beneficial effects of EFA deficiency will lead to the develop-
ment of new strategies to understand and to prevent autoimmune diabetes .
Summary
Essential fatty acid (EFA) deficiency exerts a striking protective effect in several
animal models of autoimmune disease. We now report that EFA deprivation pre-
vents diabetes in the BB rat, an animal model of human insulin-dependent diabetes
mellitus. In diabetes-prone (DP)-BB rats, the incidences of spontaneous diabetes
and insulitis (the pathological substrate of autoimmune diabetes) were greatly re-duced by EFA deficiency. This beneficial effect of the deficiency state was also seen
in diabetes-resistant (DR)-BB rats that, after treatment with antibody to eliminate
RT6+ T cells, would otherwise have become diabetic. The susceptibility of EFA-
deprived DP-BB rats to spontaneous diabetes was restored when they were given
dietary supplements of linoleate at 70 d of age (during the usual period of suscepti-
bility), but not when they were repleted beginning at 120 d (after the peak incidence
ofdiabetes). EFA deficiencydid lead to growth retardation, but calorically restricted
control rats demonstrated that the protective effect of the deficiency state was not
a function of decreased weight. To examine the relationship between the biochem-
ical changes of EFA deficiency and its physiological effects in this system, we com-
pared the fatty acid changes that occurred in EFA-deficient animals that did and
did not develop diabetes. Nondiabetic animals had significantly lower levels of (n-6)
fatty acids (i.e., linoleate and arachidonate) and higher levels ofoleate, an (n-9) fatty
acid, than did diabetic animals. Levels of 20 :3(n-9), the fatty acid that uniquely
characterizes EFA deficiency, were similar in both groups, however. Among diabetic
EFA-deficient rats, the age at onset of diabetes was found to correlate inversely with
the level of (n-6) fatty acids, the least depleted animals becoming diabetic earliest,
whereas there was no correlation with levels of 20 :3(n-9). Among animals repleted
with linoleate beginning at 70 d, restoration of susceptibility to diabetes correlated
with normalization of the level of arachidonate. In summary, EFA deprivation re-
duced the frequency of diabetes in both DP and RT6-depleted DRBB rats. This
protective effect was strongly associated with depletion of (n-6) fatty acids, particu-
larly arachidonate, but not with accumulation of the abnormal 20:3(n-9). Conjec-
turally, arachidonate and/or a metabolite may play a key role in mediating inflam-
matory injury in this animal model of autoimmune diabetes.
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